Cardiology Fiesta 2016
B

Is Coumadin Dead? Are Novel Anticoagulant Drugs the Optimal Therapy? How to Choose?

By Cardiology Fiesta 2016 FEATURING Bethany Kalich
By Cardiology Fiesta 2016 FEATURING Bethany Kalich
0 views
December 9, 2016
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
31:10
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Feat. D. Berg
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
19:47
Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Feat. U. Baber
34:40
Icahn School of Medicine at Mount Sinai

Peri-Operative Management of Anticoagulation

Feat. A. Dunn
20:50
Salim Virani

Aspirin for Primary Prevention

15:41
UCLA Health

Anticoagulation in ECLS - To Bleed, or Not to Clot...

Feat. A. Young
20:06
Canadian Collaborative Research Network

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Feat. M. Sabatine
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
16:34
AHA 2022 Conference Coverage

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

Feat. G. W. Stone
33:50
Houston Methodist DeBakey Heart and Vascular Center

Left Ventricular Thrombosis: An Overview

Feat. Y. Saleh
11:50
TCT 2023 Insights

TCT 2023 Insights: Where Do Antithrombotics Fit In?

Feat. M. Bonaca
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
45:37
Cedars Sinai

Eliquis: Alternative Anticoagulation for HeartMate 3 Ventricular Ass…

Feat. M. Slaughter
15:14
Cardiometabolic Health Congress (CMHC)

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…

Feat. D. Bhatt
19:28
James Douketis

Perioperative Considerations for Anticoagulation With Mechanical Dev…

16:55
Scottsdale Interventional Forum 2015

PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anti…

Feat. S. Bailey